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Science, University of Lugano, Lugano, SwitzerlandABSTRACT The glycocalyx is a sugar-rich layer located at the luminal part of the endothelial cells. It is involved in key meta-
bolic processes and its malfunction is related to several diseases. To understand the function of the glycocalyx, a molecular level
characterization is necessary. In this article, we present large-scale molecular-dynamics simulations that provide a comprehen-
sive description of the structure and dynamics of the glycocalyx. We introduce the most detailed, to-date, all-atom glycocalyx
model, composed of lipid bilayer, proteoglycan dimers, and heparan sulfate chains with realistic sequences. Our results reveal
the folding of proteoglycan ectodomain and the extended conformation of heparan sulfate chains. Furthermore, we study the
glycocalyx response under shear flow and its role as a flypaper for binding fibroblast growth factors (FGFs), which are involved
in diverse functions related to cellular differentiation, including angiogenesis, morphogenesis, and wound healing. The simula-
tions show that the glycocalyx increases the effective concentration of FGFs, leading to FGF oligomerization, and acts as a lever
to transfer mechanical stimulus into the cytoplasmic side of endothelial cells.INTRODUCTIONThe functioning of the human metabolism requires transfer
of nutrients, gas molecules, and hormones from the blood-
stream into the target organs. Such exchange between cir-
culating blood and the tissues occurs across a thin layer of
endothelial cells located in the luminal surface of the blood
vessels, known as the endothelium. The endothelium forms
the inner cellular lining covering the entire vascular
network, from the wide heart arteries to the smallest capil-
laries (1). Far from being an inert tissue, the endothelium
is very versatile, and it is conveniently heterogeneous (2),
adapting itself to the local environment. Moreover, the
endothelium participates actively in critical biological
processes such as blood cell trafficking, angiogenesis, and
immune response (3), and its malfunction is related to
several diseases (4,5).
The glycocalyx is the outermost part of the endothelium.
Located at the surface of endothelial cells, the glycocalyx is
the first vascular barrier in direct contact with blood. Fig. 1
shows an atomic model of the glycocalyx in the context of
the circulatory system. As its name states, the glycocalyx
is a sugar-rich layer, with carbohydrates associated by cova-
lent links forming oligosaccharide chains that can be either
long and linear or short and branched. The presence of
anionic oligosaccharides, such as heparan sulfate, provides
the glycocalyx layer with a characteristic negative charge.
Most oligosaccharides are covalently attached to membrane
proteins, but it is also possible to find that some are free and
remain adsorbed in the glycocalyx region by noncovalent
interactions. Furthermore, the glycocalyx can retain plasma
proteins recruited from extracellular space and its thickness
can be lessened by enzymatic and shear-induced shedding,Submitted April 21, 2013, and accepted for publication September 30, 2013.
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0006-3495/14/01/0232/12 $2.00producing a dynamic equilibrium between its composition
and the flowing blood (6). Due to the variety of its com-
position and its exposed location, the glycocalyx plays
two critical functions for the endothelium: as an interface
between chemical signals in the blood and biochemical
pathways inside cells; and as a barrier against chemical or
mechanical damage.
In early studies of the endothelium, the glycocalyx had
remained unnoticed because it was difficult to visualize:
the tiny sugar coat was washed out by the preparation
procedures involved in conventional light and electron mi-
croscopy. The first visual evidences of the glycocalyx
came through the employment of cationic dyes, such as
ruthenium red, which were strongly adsorbed by the nega-
tively charged glycocalyx (7). Further improvements in
staining protocols as well as in spectroscopic methods
have allowed obtaining static images of the glycocalyx
(1). Since then, research in glycocalyx has flourished and
now it is investigated as a therapeutic target against several
pathologies, such as atherosclerosis (8) and diabetes (9).
Furthermore, recent experimental studies hypothesize a
long-range effect of glycocalyx on water ordering (10),
which may mediate cell surface interactions.
Due to the experimental difficulty of tracing the elusive
atomic events inside the glycocalyx, researchers have turned
to computer simulations (11–16). Those models were
mostly based on continuum or coarse-grained approaches
but refined to include the peculiarities of the glycocalyx,
such as the negatively charged surface or the steric resis-
tance of oligosaccharide chains. Although computer simula-
tions have contributed to contemporary understanding of the
glycocalyx, structural information is still much needed to
advance the field. We turn to all-atom molecular dynamics
(MD) simulations, which provide the most detailed and dy-
namic representation of biomolecular systems (17,18).http://dx.doi.org/10.1016/j.bpj.2013.09.060
FIGURE 1 Glycocalyx in the circulatory system. (a) A cartoon represen-
tation of a blood vessel: (orange circles) endothelial cells; (green brush)
glycocalyx. (b) All-atom model of the glycocalyx. (Green licorice repre-
sentation) Sugar chains. (Red surfaces) Transmembrane protein; (van der
Waals beads) lipid bilayer. Water and ions are not shown.
Flow Response of the Glycocalyx 233Here, we report large-scale, all-atom MD simulations of
the glycocalyx layer. To begin, we describe a procedure to
build all-atom models of glycocalyx. We present structural
insight obtained while building the model: the folding of
the ectodomain of proteoglycans, the extended conforma-
tion of sugar chains, and the negligible effect of sulfonation
charge on the chain length. Finally, our model was simu-
lated under nonequilibrium conditions to address two
fundamental questions about the glycocalyx: its response
to mechanical stimuli under shear flow, and its ability to
retain fibroblast growth factor (FGF) proteins.METHODS
MDsimulations compute the time-evolution of amany-body systemby solv-
ing Newton’s equations of motion. Two compulsory requirements for MD
simulations are the initial atomic positions of particles, and the force field
describing the interactions between particles. The glycocalyx is intrinsically
disordered and it is not possible to obtain a minute atomic structure by NMR
or crystallography; thus, the atomic models relevant to this discussion were
built based on the available structural information as detailed below.
The MD simulations are organized into three groups:
The first group involves simulations (Sim) needed to build the glycocalyx
structure (Sim1–32 in Table 1): i.e., annealing of ectodomain (Sim1–24),
equilibration of transmembrane (Sim25–26) and cytoplasmic (Sim27–28)
domains, and the assembly of 5,700,000-atom glycocalyx systems
(Sim29–32).The second group relates to glycocalyx simulations under shear flow
(Sim33–35).
The third group lists simulations used to study binding of proteins to the
glycocalyx (Sim36–40).Building the glycocalyx
We chose Syndecan-4 (Syn-4) proteoglycan and heparan sulfate (HS) sugar
chains for modeling the glycocalyx as described in the Results and Discus-
sion. Below we provide information about assembly protocol, simulation
time, and system size.
We initially divided the glycocalyx structure into three parts: Syndecan-4
ectodomain (Syn-4 Ect) linked with sugar chains; Syndecan-4 transmem-
brane (Syn-4 Tmb) dimer embedded into a lipid bilayer; and Syndecan-4
cytoplasmic (Syn-4 Cyt) dimer. Fig. S1 in the Supporting Material shows
the three separate systems. After reaching equilibration for each part, the
sections were glued together into a single glycocalyx system and equili-
brated further.
For Syn-4 Ect simulations (Sim1–24), our starting structure was a fully
stretched ectodomain joined with three extended 100-residue sugar chains.
Subsequently, the structure was annealed as follows: the system was heated
at 1000 K for 10 ns, then cooled down to 310 K at a rate of 100 K/1 ns.
After that, the structure was checked for stereochemical correctness (19).
The final annealing stage was an equilibration of 100 ns, summing a total
of 116 ns per annealing cycle. The tested range of temperatures does not
allow employing all-atom water models; therefore, an implicit solvent
model was used. We simulated four different HS sequences (see Fig. 2
and the Results and Discussion). Six different conformations were tested
for each HS sequence. The chains orientations were random, but avoided
overlapping contacts between residues. All together, the simulation time
spent in annealing cycles was
ð4 HS optionsÞð6 conformationsÞ
ð116 ns per cycleÞ ¼ 2:784 ms:
For Syn-4 Tmb simulations, we mapped two Syn-4 backbones into a re-
ported Glycophorin-A dimer structure (20) (PDB:1AFO; see Results and
Discussion). Weinbaum et al. (15) have proposed a hexagonal symmetry
for glycocalyx. In accordance with such model, Syn-4 transmembrane di-
mers were embedded into a POPC lipid bilayer of hexagonal periodicity
and 820 nm2 area. The lipid membranes were generated from a preequili-
brated membrane patch provided with the MEMBRANE BUILDER plugin
available in the software package VMD (21). Two systems were built, the
first containing one Syn-Tmb dimer, the second with three Syn-Tmb dimers
equally spaced among themselves and their periodic images. Then, the sys-
tems were covered with water boxes resulting in 11-nm height each. Both
systems were equilibrated in NPT ensemble for 5 ns (Sim25–26).
For Syn-4 Cyt simulations, we solvated and ionized a Syn-4 cytoplasmic
dimer (22) (PDB:1EJP) using a water box of 8  8  9 nm3. Then, the
system was equilibrated for 5 ns in NPT ensemble (Sim27), followed by
5 ns in NVT (Sim28).
The final stage is to join all three parts: the transmembrane domain con-
tains residues 141–171; the ecto domain, 1–141; and the cytoplasmic domain,
171–198 (see Fig. 2). The repeating residues in the transmembrane part were
used as guiding positions to attach the other domains. Special carewas taken
to avoid sugar rings either intersecting each other across the periodic images
or overlapping themembrane region. Once the three partswere joined, topol-
ogy was reconstructed around the new bonds and the entire structure was
checked for chirality correctness. Two systemswere built, with one and three
Syn-4 dimers, then solvated and ionized to 100mMNaCl concentration. The
final systems are composed of 5,700,000 atoms,with 820 nm2 area and 69 nm
height. MD equilibrations proceeded as follows: 3.5 ns in NPT ensemble
(Sim29–30) and 5 ns in NVT (Sim31–32). The final equilibrated structures
for both glycocalyx systems are provided in the Supporting Material.Biophysical Journal 106(1) 232–243
TABLE 1 Summary of MD simulations (Sim)
Label Typea Atoms (1000) Time (ns) Solvent modelb Starting structurec
Sim1–6 Annealing 9 116 I Syn-4 Ect and [NA-NA/NS-NS] sequence
Sim7–12 Annealing 9 116 I Syn-4 Ect and NA sequence
Sim13–18 Annealing 9 116 I Syn-4 Ect and NS sequence
Sim19–24 Annealing 9 116 I Syn-4 Ect and NAH sequence
Sim25 Eq-NPT 955 5 E Syn-4 Tmb dimer
Sim26 Eq-NPT 955 5 E 3 Syn-4 Tmb dimers
Sim27 Eq-NPT 58 5 E Syn-4 Cyt dimer
Sim28 Eq-NVT 58 5 E Sim27
Sim29 Eq-NPT 5700 3.5 E Gccx (Glycocalyx) (1 Syn-4 dimer)
Sim30 Eq-NPT 5700 3.5 E Gccx (Glycocalyx) (3 Syn-4 dimers)
Sim31 Eq-NVT 5700 5 E Sim29
Sim32 Eq-NVT 5700 5 E Sim30
Sim33 Flow-NVT 5950 0.6 E Sim31
Sim34 Flow-NVT 5950 1.5 E Sim31
Sim35 Flow-NVT 5950 10 E Sim31
Sim36 NVT 20 10 I 10 FGF-2
Sim37 GSMD-NVT 20 10 I Sim36 and 1 Syn-4 dimer grid
Sim38 GSMD-NVT 20 10 I Sim36 and 3 Syn-4 dimer grid
Sim39 NVT 20 10 I Sim37
Sim40 NVT 20 10 I Sim38
Table presents the simulation effort for building (Sim1–32), flow (Sim33–35), and binding simulations (Sim36–40).
aEq, equilibration; GSMD, Grid-SMD; NVT, constant volume; NPT, constant pressure.
bI, generalized Born implicit solvent; E, TIP3P explicit solvent.
cSyn, Syndecan; Ect, ectodomain; Gccx, glycocalyx.
234 Cruz-Chu et al.Shear-stress effect on glycocalyx conformation
We study the effect of flow on the glycocalyx conformation by applying
forces on the water molecules to mimic shear-stress. Our starting structure
was the last frame of simulation Sim32. It is worth noting that the system is
periodic in the three axes. Therefore, shear-stress applied on the ecto-
plasmic side would propagate to the cytoplasmic side through the z-periodic
boundary and not across the Syn-4 dimers embedded in the lipid membrane.
To avoid this caveat, the system was modified along the z axis by adding a
layer of eight graphene sheets, located 51 nm above the lipid membrane.
The graphene layer has a thickness of 2 nm, the same area as the lipid mem-
brane, and it is periodic in x- and y axes, creating an effective division
between two compartments: the ectoplasmic compartment from the top
of lipid membrane to the bottom of the graphene layer; and the cytoplasmic
compartment from the bottom of lipid membrane to the top of the graphene
layer. All HS sugar chains are contained in the ectoplasmic compartment.q       = -88 e
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Biophysical Journal 106(1) 232–243The graphene layers were created using the INORGANIC BUILDER plu-
gin (23) in the software VMD. The system containing the glycocalyx and
graphene barrier was minimized for 1000 steps and equilibrated for
0.2 ns in NPT ensemble. Graphene atoms were restrained in the x- and y
axes to keep the area constant. For production runs (Sim33–35), the gra-
phene layer remains fixed; therefore, shear-stress cannot cross the z-peri-
odic boundary. The forces are applied on the water oxygens located in
the upper half of the ectoplasmic compartment. The direction of the force
is along the x axis, parallel to the lipid membrane.Glycocalyx binding
We study the effects of the glycocalyx on flowing proteins using grid-
steered molecular dynamics (Grid-SMD) simulations. In Grid-SMD, the
key feature of the glycocalyx, namely its electrostatic potential, is mappedSer
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Flow Response of the Glycocalyx 235into a three-dimensional grid. Overall, the protocol for binding simulations
is similar to the molecular-dynamics flexible fitting technique (24), where
biomolecules are force-fitted into cryo-electron microscopy grids. In our
case, the flowing proteins are force-driven into glycocalyx grids. The grids
were calculated using the PMEPOT (25) plugin available with the software
VMD. PMEPOT calculates the electrostatic potential from a MD trajectory
by recomputing the long-range electrostatic forces via particle-mesh Ewald
(PME) (26). Two grids were computed, one for the system with one Syn-4
dimer, the other for the system with three Syn-4 dimers. We characterized
the glycocalyx grids by the average electrostatic potential of 5-ns MD
equilibration trajectories (Sim31 and 32), using only the atomic charges
of HS chains, whereas other components, such as Syn-4 dimers, lipid mem-
brane, and electrolytic solution were not included. This simplification was
necessary to provide a smooth potential that drives flowing proteins near
highly charged sugar locations within dozens of nanoseconds. In the Sup-
porting Material, we include references to a Grid-SMD tutorial and the gly-
cocalyx grids.
The flowing protein is fibroblast growth factor-2 (FGF-2) (PDB:1BFB).
We refer to the Results and Discussion for more details about FGF-2. To
induce flow, a force of 1 pN was applied to the a-carbons of FGF-2, with
the direction of the force being along the x axis. For binding simulations,
we performed a three-step MD cycle.
For the first part (Sim36), 10 all-atom FGF-2 proteins were randomly
distributed on a region from 14 to 39 nm above the membrane location.
The minimum distance between FGF-2’s centers of mass was 5 nm. Peri-
odic boundary conditions were assumed, and the periodic lengths matched
the glycocalyx grid dimensions. Then, FGF-2 molecules were allowed to
flow for 10 ns.
For the second part, two separate 10-ns MD simulations were performed,
one with the single Syn-4 dimer glycocalyx grid (Sim37) and the other with
the three Syn-4 dimer glycocalyx grid (Sim38). The starting point was the
last frame of Sim36, but now the glycocalyx grids were active, affecting
FGF-2 flow dynamics.
For the third part, both Sim37 and 38 simulations were continued for
10 ns, but the glycocalyx grids were turned off (Sim39 and 40, respec-
tively). For all three parts, implicit solvent was used. To maintain FGF-2
structure, secondary structure restraints were used and the steering forces
derived from the grid were scaled up by a factor of 0.05. The system size
was 20,180 atoms, consisting of only 10 FGF-2 molecules.c
FIGURE 3 Ectodomain folding. (a) Plot shows the time evolution of sec-
ondary structure for Syn-4 ectodomain during the annealing cycle. Abscissa
and ordinate axes show time and residue number, respectively. (Vertical
lines) The three annealing stages: 10 ns heating at 1000 K, 6 ns cooling
from 1000 to 310 K, and final 100-ns equilibration at 310 K. (Shaded
bands) Appearance of a-helical structure. (b) RMSD of a-carbons of
Syn-4 during equilibration at 310 K. (c) (Snapshot) Last frame of simula-
tion, with (shaded ribbons) a-helices, (solid spheres) proline residues,
and (lines) HS chains.Protocol details
All MD simulations were performed using the software program NAMD
2.7 (27). We used the CHARMM biomolecular force field (28) and the
TIP3P water model (29). Structures were generated using the PSFgen utility
provided with the VMD program. The latest additions to CHARMM
include parameters for sugars (30–32).To assure compatibility with
PSFgen, atom types were renamed from the six-letter code given in the
CHARMM force field into a four-letter code. Sulfamate group parameters
(R-NHSO13) needed for sulfonated GlcNAc were taken from Huige and
Altona (33).
For MD simulations with implicit solvent, namely annealing (Sim1–24)
and binding (Sim36–37) simulations, we used 1-fs timestep and flexible
bonds. We employed the generalized Born implicit solvent (34) that accu-
rately represents the dielectric screening between solute molecules in elec-
trolytic solution. The van der Waals and electrostatic interactions were
calculated using a cutoff of 16 A˚ with a switching function starting at
15 A˚ and 0.1 M electrostatic screening. Temperature was controlled using
a Langevin thermostat. For MD simulations with explicit water (Sim25–
35), we used a 2-fs timestep, rigid bonds, and PME electrostatics with a
grid density of 1/A˚3. The van der Waals interactions were calculated using
a cutoff of 12 A˚ with a switching function starting at 10 A˚. Simulations in
NPTensemble were kept at 1 atm pressure and 310 K using a Langevin ther-
mostat and a Nose´-Hoover Langevin piston. Simulations in the NVT
ensemble were kept at 310 K using the Andersen thermostat. To simulate6,000,000 atom systems, we used the memory-optimized version of
NAMD (35).
The analysis was performed using VMD (Visual Molecular Dynamics,
University of Illinois at Urbana-Champaign, Champaign, IL), MATLAB
(The MathWorks, Natick, MA), and PYTHON (Python Software Founda-
tion, Wilmington, DE) scripts. All MD snapshots were made with VMD.
The secondary structure plots (Fig. 3 a), were computed using the TimeLine
plugin in VMD. To calculate the velocity profiles, the system was divided in
layers of 1 nm height along the z axis; for each layer, the velocities in the x
axis of water oxygens were averaged. The shear stresses (t) were computed
from the resulting velocity profiles as
t ¼ m dv
dz
;
where m is the viscosity of the TIP3P water model (36) (0.321 mPa, s); and
dv/dz is the gradient of the x velocity along the z axis. The persistence length
(PC) was calculated using the relationship

e2e2
 ¼ 2PCLC  2P2C½1 expðLC=PCÞ;
where he2e2i is the averaged squared end-to-end distance, LC is the contour
length, and PC is the persistence length (37).Biophysical Journal 106(1) 232–243
236 Cruz-Chu et al.RESULTS AND DISCUSSION
Building glycocalyx system
The glycocalyx layer is composed of sugar chains cova-
lently linked to transmembrane proteins located at the sur-
face of endothelial cells. A complete all-atom model of
the glycocalyx is notoriously difficult to build: the oligosac-
charide chains are very heterogeneous in structure and
sequence to be resolved by crystallization or NMR and
only low-resolution images are available (38–40). To over-
come this problem, most glycocalyx models have only
considered some key features such as negative charge or
polymer hindrance (11–16), while disregarding other
equally important features such as nonuniform charge distri-
bution, realistic sugar chain length, or interactions among
the different biomolecular components.
We aimed to build the most detailed all-atom glycocalyx
model using structural information. Some degree of simpli-
fication is required for a system with such high structural
heterogeneity, but we did preserve the molecular compo-
nents that are most prevalent in glycocalyx. The most abun-
dant oligosaccharides in the glycocalyx are heparan sulfate
(50–90%) and chondroitin sulfate (10–20%) (6). Accord-
ingly, our glycocalyx considers heparan sulfate (HS) chains.
The anchoring transmembrane proteins for HS chains are
syndecans. We chose Syndecan-4 (Syn-4), which is widely
distributed among all endothelial cells, in contrast to other
syndecans that are localized in specific tissues (41). Syn-4
is a proteoglycan of 198-amino-acid length, containing
extracellular, transmembrane, and cytoplasmic domains.
The extracellular domain (i.e., the ectodomain) contains
three points for attaching HS molecules (42). Fig. 2 presents
the employed Syn-4 and HS sequences.
Based on data from electron microscopy images (38),
Weinbaum et al. (15) have presented a quasiperiodic hexag-
onal arrangement for a glycocalyx with a spacing of 100 nm
between proteoglycan clusters. Also, HS chains are long
linear polymers of ~100–200 sugar residues, corresponding
to 50–100-nm length (1,43). An all-atom model with
such spacing and dimensions would demand ~100,000,000
atoms, which is at the limit of contemporary MD capabil-
ities. To reduce the computational cost of building the struc-
ture, the system was initially split into three smaller pieces:
Syn-4 ectodomain linked with HS chains; Syn-4 transmem-
brane dimer embedded into a lipid bilayer; and Syn-4 cyto-
plasmic dimer (see Methods).
The first topology block is Syn-4 ectodomain joined with
three HS chains. The HS length is assumed to be 100 sugar
residues (44). The HS chains are covalently attached to three
serine residues at positions 39, 61, and 63 in the ectodomain.
The linker between HS and ectodomain has been described
in other publications (6,45). In short, HS and Syn-4 are
joined through a tetrasaccharide GlcA-[b1–3]-Gal-[b1–3]-
Gal-[b1–4]-Xyl (see Fig. 2). At the reducing end (right-
hand side of Fig. 2, b–e), a xylose sugar attaches to a serineBiophysical Journal 106(1) 232–243amino acid through b1 glycosidic linkage. The HS chain
grows at the nonreducing end (left-hand side of Fig. 2,
b–e) by adding either GlcA-[b1–4]-Glc-[a1–4] or IdoA-
[a1–4]-GlcNAc-[a1–4] disaccharide units. The former
disaccharide appears in nonsulfonated form, also known
as the NA region. The latter disaccharide can be either
partially sulfonated (NA/NS region) or highly sulfonated
(NS region). A HS chain usually contains alternating NA,
NA/NS, and NS regions of variable length, and the specific
sequence seems to correlate with the cell type origin (45).
Although increasing evidence suggests precise sulfonation
patterns with strong specificity for particular proteins (46),
current experimental techniques can only partially resolve
HS sequences (47). To provide the closest model to a real
glycocalyx, the sulfonation patterns for NS and NA/NS re-
gions were chosen to bind fibroblast growth factor and
antithrombin, respectively (45) (see Fig. 2 b). At the non-
reducing end, we adopted the sulfonation pattern proposed
by Wu and Lech (48).
Due to the presence of 12 proline residues and a lack of
homology structures, the ectodomain is usually depicted
in a centipedelike representation; that is, as an elongated
protein stretching away from the cellular membrane with
HS chains branching out from the unfolded protein back-
bone (1,41,44,49,50). Because MD simulations have been
remarkably successful in the study of folding processes
for proteins of similar size (51), we decided to test the ecto-
domain structure using a simulated MD annealing proce-
dure (see Methods). We took advantage of the small
system size, ~9000 atoms, to simulate four HS sequences.
For each HS sequence, six simulations were performed, us-
ing different initial conformations. The sequence employed
were: a combination of NA-NA/NS-NS domains (Fig. 2 b,
Sim1–6); a nonsulfonated NA domain (Fig. 2 c, Sim7–
12); a fully sulfonated NS domain (Fig. 2 d, Sim13–18);
and a chimeric protonated domain, called NAH (Fig. 2 e,
Sim19–24).
Fig. 3 shows the ectodomain folding for one annealing
cycle with NA-NA/NS-NS sugar chains. Similar plots
were observed for all systems and the use of NA, NS, and
NAH sequences did not lead to any significant difference
in folding. Fig. 3 a reveals the appearance of secondary
structure in the ectodomain. There is no protein structure
during the heating stage, but as the system is cooled down
and progresses in the 310 K equilibration stage, a-helices
form at both ends of the ectodomain.
It is worth noting that the linker positions remain
unfolded and accessible. Moreover, the structure is still
highly flexible. Fig. 3 b shows the RMSD calculated from
a-carbons during the equilibration stage. After 40 ns of
initial folding, the RMSD oscillates within a wide region
of 1.5 nm, lacking the plateau characteristic of stable folded
structures. Our results propose a very mobile ectodomain
with a combination of folded conformation at both ends
and unfolded coils at the center, where HS molecules are
Flow Response of the Glycocalyx 237linked. Fig. 3 c shows a snapshot of the final frame of an-
nealing. Conversely, there was no appearance of compact
structure for the HS chains, and they remain unfolded for
all sequence options.
Fig. 4 shows the average end-to-end distance for HS
chains during the 310 K equilibration stage. Remarkably,
such distance is approximately the same for different HS
sequences—insensitive to the total charge and sulfonation
pattern. The lack of correlation between sequence and
end-to-end distance in our annealing simulations is attrib-
uted to three causes:
1. The HS chains are hydrophilic; therefore, they favor the
extended conformation in solution.
2. There is a limitation of the solvent model, the generalized
Born implicit solvent,which does not compute long-range
electrostatic forces. Such long-range interaction should
affect the conformation of a highly charged polymer.
3. There is a lack-of-crowding effect, in which each anneal-
ing simulation contains only three HS chains. A higher
HS concentration should force the HS chains to stretch
due to electrostatic repulsion and steric clashes.
A quantity of interest is the bending stiffness (EI), which
is widely used in mesoscopic models of glycocalyx (43,52).
We estimated the EI of HS chains using the final stage of the
annealing cycle, namely the equilibrations at 310 K for
100 ns. To represent stiffness, we first calculated the persis-
tence length (PC). The procedure to compute PC is described
in the Methods. Then, we employed
PC ¼ EI
kBT
; (1)
where kB is the Boltzmann constant, and T is 310 K.
PC was calculated for all four sulfonation patterns. A ta-
ble listing PC and EI values is included in the Supporting0 20 40 60 80 100
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FIGURE 4 Effect of sulfonation pattern on the conformation of HS
chains. The plot shows end-to-end distance for all HS sequence alternatives.
Each point represents an average taken over 18 HS chains. Error bars repre-
sent5 SD taken over 18 HS chains. Overlapping regions in the error bars
highlight the variability in the end-to-end distance values.Material. Similar to the end-to-end distances, the PC for
HS chains was not sequence-dependent. Also, the PC values
were highly variable, with a mean value of 15.92 nm, in
good agreement with previously reported PC values for
all-atom sugar models (37).
The EI mean value for HS chains is 68.28 pN nm2,
approximately an order-of-magnitude lower than 490 pN
nm2, the value commonly used in continuum models.
Note that to obtain an EI of 490 pN nm2, the PC value should
be 114.5 nm, which is unrealistic for HS chains. We
conclude that the high EI value for glycocalyx cannot be
attributed to the HS chains alone. The other macromolecular
components of the glycocalyx, such as plasma proteins and
adsorbed carbohydrate chains, contribute to an enhanced
stiffness. Although our glycocalyx models include atomic
information, they still lack the heterogeneity added by the
adsorbed molecules.
The second topology block is the transmembrane domain.
As yet, there is no high-resolution structure available; never-
theless, there is cumulative experimental evidence that all
syndecans have a-helical transmembrane domains and
appear as dimers (53,54). In a recent computational study,
Psachoulia et al. (55) have shown that Syn-2 and Glyco-
phorin-A share the same transmembrane dimer packing,
where both a-helices are in contact through a GXXXG
sequence motif. Because Syn-2 and Syn-4 transmembrane
domains share 78% amino-acid identity and the GXXXG
motif (residues 153–157, see Fig. 2 a), we overlapped two
Syn-4 backbones into a reported Glycophorin-A dimer
structure. Dimer transmembrane domains were inserted
into a POPC lipid bilayer. Two systems were built, the first
with one dimer, the second with three dimers, then inserted
into a lipid bilayer and equilibrated as described in Table 1.
The last topology block, namely the cytoplasmic domain,
is well characterized experimentally and high-resolution
dimeric structures are available. During equilibration, the
structure remained as a dimer, but both ends showed high
mobility. Certainly, we hypothesize that attachments to the
transmembrane domain at N-terminus and to actin filaments
at the C-terminus are necessary to restraint mobility.
The final stage is to join all three parts into a single
glycocalyx system, then solvate and ionize it, resulting in
a system of 5,700,000 atoms. The entire glycocalyx system
was equilibrated further (Sim29–32). Equilibrium states
were checked by convergence of temperature, volume, pres-
sure, and total energy. A snapshot of the final frame for the
three Syn-4 dimer systems with periodic images is presented
in Fig. 1 c. Movie S1 in the Supporting Material shows the
NVT equilibration of the three-dimer system.Shear-stress effect on glycocalyx conformation
The endothelial cells are responsive to mechanical stimuli
from the flowing blood (56), controlling vessel diameter
(57), vessel permeability (58), and flux of biochemicalBiophysical Journal 106(1) 232–243
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FIGURE 6 Conformational change of glycocalyx for 0.47 MPa shear
stress flow simulation. (a) The contour plot shows the charge density of
HS chains in the ectoplasmic compartment. The abscissa represents time;
the ordinate represents position above the lipid membrane. The values of
the charge density are color-coded according to the color-bar at the right.
(b) The plot shows the variation of angle for the three cytoplasmic domains
238 Cruz-Chu et al.signals (59,60). The glycocalyx is in direct contact with the
bloodstream and mediates these stimuli by transmitting the
flow-induced shear stress and pressure into the interior of
endothelial cells. In turn, the glycocalyx conformation
also affects the migration of blood cells and plasma proteins
through the vasculature.
We study the effects of shear flow using one of our glyco-
calyx structures, namely the system with three Syn-4 dimers
and 18 HS chains (Fig. 1 c), which has the highest glycoca-
lyx concentration. To induce shear stress, we apply forces on
the solvent located in the ectoplasmic side. We performed
three simulations in the NVT ensemble, using forces of
0.1 pN (Sim33), 0.01 pN (Sim34), and 0.001 pN (Sim35).
Such forces result in applied shear stress values of 30.42,
3.63, and 0.47 MPa, respectively.
The flow simulations with shear stress of 30.42 and 3.63
MPa damage the integrity of glycocalyx, as the Syn-4 ecto-
domains unfold. Fig. S2 shows the final frames of those sim-
ulations. For flow simulation under shear stress of 0.47 MPa,
Syn-4 ectodomains maintain their structures and only the
HS chains are straightened by the flow. Fig. 5 shows the
initial and final frame as well as the velocity and shear stress
profiles. The velocity profile is largely parabolic above the
glycocalyx, but it becomes approximately linear inside the
sugar layer. Accordingly, the highest shear stress is observed
at the top border of glycocalyx and it decreases close to the
membrane.
We further analyzed this simulation by computing the HS
charge density and the cytoplasmic domain conformation.
Fig. 6 a presents the time-evolution of HS charge density.v
τ
-0.4 0 0.4 0.8
shear stress / MPa
40
30
20
0
10
50
Z-
po
si
tio
n 
/  
nm
0 2 4 6 8 10
velocity  /  ms-1
a c
b
FIGURE 5 Effect of shear flow on glycocalyx conformation. (a) Initial
conformation of the system: a glycocalyx layer composed of three Syn-4
dimers (solid) embedded into a lipid bilayer (dark shaded) and 18 HS
chains (light shaded). The flow is applied on the upper half of the ecto-
plasmic compartment (see text). A graphene barrier was located at 51 nm
above the lipid membrane (not shown here). (b) Bending of glycocalyx un-
der 0.47 MPa shear stress. (Snapshot) Simulation after 10 ns, periodic im-
ages of the lipid membrane are shown repeated along the x axis. (c) Velocity
(solid squares) and shear stress profiles (shaded circles).
of Syn-4 dimers; each line represents one dimer.
Biophysical Journal 106(1) 232–243Initially, the charge density occupies a region up to 45 nm
above the lipid membrane. As the flow impacts the HS
chains, the glycocalyx conformation changes, crowding
the HS chains into a smaller volume. The charge distribution
changes accordingly, compressing the negative charges into
a region of 30 nm within the membrane. Although the flow
changes the distribution of charges from 45 to 30 nm above
the membrane, the highest charge concentration remains
located in a region between 10 and 15 nm above the mem-
brane during the entire simulation (see Fig. 6 a). Further-
more, the simulation reveals that Syn-4 dimers act as
levers, moving the cytoplasmic domains in the opposite
direction of the shear flow. To quantify the cytoplasmic
bending, we measured the angle q between each cyto-
plasmic dimer and the z axis. Fig. 6 b shows the cosine of
q for the three cytoplasmic domains, where value 1 repre-
sents cytoplasmic alignment with the z axis and value 0 rep-
resents cytoplasmic domain is parallel to the membrane. As
observed, the three cytoplasmic domains bend toward the
membrane during the simulation. In endothelial cells, the
Syn-4 cytoplasmic domains are connected to transduction
complexes and actin filaments, and it is expected that cyto-
plasmic angling should move the anchoring points in the
Flow Response of the Glycocalyx 239cytoskeleton, triggering the biochemical machinery inside
the cell. The Movie S2 shows the flow simulation under
0.47 MPa shear stress.0 10 20 30
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FIGURE 7 Glycocalyx affects mobility of FGF proteins. The panels
show flow simulations of FGF-2s turning on and off the electrostatic poten-
tial of glycocalyx. (Open, shaded, and open backgroundsmark states as off,
on, and off for glycocalyx electrostatic fields, respectively.) (a and b)
Average velocities for FGFs using one-Syn-4 dimer and three-Syn dimer
grids, respectively. (c and d) Average positions for FGFs using one-Syn-4
dimer and three-Syn dimer grids, respectively. Each point represents an
average taken over 10 FGF-2s. Error bars represent 5 SD taken over 10
FGF-2s.Glycocalyx binding
Another puzzling aspect of the glycocalyx is its role as a
flypaper for molecules flowing in the blood; that is, its abil-
ity to recognize and retain extracellular ligands. This is a
critical function, because ligands deliver biochemical sig-
nals to endothelial cells. An extensive variety of HS-binding
ligands has been reported, including growth factors, extra-
cellular matrix proteins, cell-cell adhesion receptors, and
blood-coagulation factors (42). Among the most studied
ligands are fibroblast growth factors (FGF). The FGF family
is composed of at least 20 related proteins and it is involved
in several cellular functions, such as proliferation, migra-
tion, morphogenesis, and angiogenesis (61). In particular,
the FGF-2 protein is a well-documented case, as several
high-resolution structures of FGF-2 in contact with HS
chains are available (62,63). FGF-2 functions by promoting
dimerization of specific transmembrane proteins, called
FGF-receptors (FGFR). FGF-2 molecules alone cannot
gather FGFRs, and HS chains are needed to retain FGF-2
at the cell surface. As FGF-2s, HS chains, and FGFRs aggre-
gate into macromolecular complexes, FGFRs dimerize and
transfer the stimulus inside endothelial cells. Nevertheless,
the molecular mechanism behind the aggregation of FGFs
and HS chains is still a matter of debate (64).
We studied the effect of glycocalyx on FGF-2 dynamics.
In principle, all-atom MD simulations can fully characterize
the dynamic interplay between ligands and receptors, as it
has been shown before for systems of up to 100,000 atoms
(65,66). Unfortunately, the size of our glycocalyx system
(5,700,000) exceeds that range. Moreover, FGF-2 is more
massive than typical small ligands, and a thorough equili-
bration between FGF-2 and glycocalyx may require hun-
dreds of nanoseconds or microseconds. To overcome these
limitations, we employed the Grid-SMD technique, which
reduces the system size by coarse-graining the atomic de-
tails of glycocalyx into a grid. Then, FGF-2 molecules
diffuse on the glycocalyx grid; the interacting forces be-
tween FGF2 and glycocalyx are calculated from the grid
potential. The Grid-SMD approach was initially proposed
for studies of electric field-driven transport (25), and as
such it is well suited to study how FGF-2 transport is
affected by a highly charged polymeric brush. Grid-SMD
simulations reduce the system size from millions to thou-
sands of atoms, and smooth the energy landscape for fast
FGF-2 diffusion. The grids that we employed do not take
into account the steric hindrance of the glycocalyx and
only consider the mean electrostatic field of the sugar
chains. Recent developments in the Grid-SMD technique
allow the addition of extra molecular information. For
example, steric hindrance can be included by adding a sec-ond grid potential that represents a three-dimensional poten-
tial of mean force (67,68).
For binding simulations, we performed an on-and-off MD
cycle, with the glycocalyx grids acting intermittently on
FGF-2 molecules under flow. The MD cycle consists of
three consecutive parts: FGF-2 molecules flowing free;
then flowing under the effect of glycocalyx grids; and
then, finally, flowing free again. Such an MD cycle mimics
the process of protein flowing, binding in the glycocalyx,
and subsequent release, which can occur by enzymatic
cleavage of the sugar chains (69). The movie S3 shows
the on-and-off MD cycle using one-dimer grid.
Fig. 7 shows the effect of glycocalyx grid on FGF-2’s
mobility, which is characterized by measuring the FGF-2’s
average velocity (Fig. 7, a and b) and average position
from the membrane surface (Fig. 7, c and d). Fig. 7, a and
c, refers to one Syn-4 dimer grid (Sim37), whereas Fig. 7,
b and d, refers to three Syn-4 dimer grids (Sim38).
For the first part of the cycle, the first 10 ns (Sim36; open
backgrounds at left), the FGF-2 molecules move in the
direction of the flow with varying velocities (Fig. 7, a and b),
and retain their distance from the lipid surface (Fig. 7, c and d).
The second part of the cycle, the activation of glycocalyx
grids, is marked by the shaded areas in Fig. 7. FGF-2 mol-
ecules still move in the direction of the flow, but the grid
forces slow down the proteins and the average velocities
decrease (Fig. 7, a and b). Remarkably, FGF-2 moleculesBiophysical Journal 106(1) 232–243
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FIGURE 8 Glycocalyx induces aggregation of FGF proteins. (a and b)
Flow simulations of FGFs turning on and off the electrostatic potential of
glycocalyx. The images show schematic representations of FGF aggrega-
tion under the effect of one dimer (a) and three dimer (b) glycocalyx elec-
trostatic fields. (Circles) FGF aggregates. For each time frame shown, the
aggregates are sorted based on their total mass. The number of FGFs in
each aggregate is coded in the size and grayscale (see inset). (Shaded back-
grounds in the axes) Activation of the glycocalyx electric fields. (c) (Snap-
shot) FGF pentamer. (Transparent surface) Isosurface of electrostatic
potential.
240 Cruz-Chu et al.move close to the membrane position (Fig. 7, c and d). The
FGF-2 molecules concentrate in the region of high HS
charge density (time zero at Fig. 6 a). These simulations
suggest that the glycocalyx contributes to gather FGF-2s
near the lipid membrane, increasing the effective concentra-
tion of FGF-2, which is needed for FGFR activation.
The third part of the cycle is shown in open backgrounds at
right. Both simulations were continued, but now the glycoca-
lyx grids were turned off (Sim39 and 40). The FGF-2 veloc-
ities start to increase (Fig. 7, a and b); however, the position
from the membrane remains unchanged (Fig. 7, c and d).
It is well established that HS induces not only binding
but also oligomerization of FGFs; namely, the formation
of FGF dimers or tetramers along the HS chains (70).
FGF oligomerization can be an essential step for FGFR ac-
tivity, as it has been hypothesized that FGF oligomers are
needed for FGFR dimerization (71,72). During our binding
simulations, we observed the formation of FGF-2 aggre-
gates. Each FGF-2 protein has a charge of þ11 e, and con-
tains an amino-acid binding sequence KRTGQYKLGS
KTGPGQK (each letter refers to one-letter abbreviation
code for amino acids) to recognize HS chains. As the
FGF-2 molecules race toward the negatively charged posi-
tions in the glycocalyx grids, they get close to each other
and assemble into FGF-2 oligomers. To provide a quantita-
tive description of FGF-2 oligomerization, we used an
iterative nearest-neighbor search procedure to identify ag-
gregates (73). If the centers of masses of FGF-2s are within
a cutoff distance of 4 nm, the proteins are considered in con-
tact and part of an oligomer. Fig. 8, a and b, shows the FGF-
2 oligomerization for one- and three-dimer glycocalyx
grids, respectively. Shaded backgrounds in the x axes
mark the time region where the glycocalyx grids are active.
Each circle represents a FGF-2 aggregate; the radius and
grayscale provide information about the aggregate’s size
(see legend). Such snowman-like plots provide a schematic
representation of the aggregation process over time.
In the first 10 ns, when the glycocalyx grids are not active,
FGF-2 molecules flow individually across the periodic cell
and do not oligomerize. When the grids are active (shaded
backgrounds), monomers crowd near the highly charged
positions in the grid (see also Fig. 7, c and d), forming olig-
omers of varying sizes. The most remarkable is a short-lived
pentamer (snapshot in Fig. 8 c), which eventually breaks
into a dimer and a trimer. For the last 10 ns, the grids are
turned off again. The newly-formed protein-protein inter-
faces of dimers and trimers remain stable under the flow.
The existence of similar side-by-side dimers, so-called cis
dimers, is still under discussion (64), mostly because there
is no crystallographic evidence yet. It is tempting to state
that our simulations confirmed the existence of cis dimers.
However, because the binding simulations are short, the sta-
bility of those oligomers is difficult to assess. We have
inspected the trajectories of Sim37–40, where FGF2 oligo-
mers appeared, searching for specific FGF2 contacts thatBiophysical Journal 106(1) 232–243are known to stabilize in FGF2-FGFR interface (63,74).
Although we were able to identify the hydrophobic patch
NYL (N102-Y103-L140 in Plotnikov et al. (74)) as a part
of the interface in one of the trimers, most of the contact
surfaces are different. Therefore, it is likely that the olig-
omer contacts are nonspecific and may eventually dissociate
if simulated longer.
Altogether, our results provide a generic mechanism of
FGF-2-HS molecular interplay: The highly charged glyco-
calyx force the intrusion of FGF-2 proteins near the mem-
brane position. Then, the negatively charged positions in
the glycocalyx act as nucleation centers for FGF-2 oligo-
merization. FGF-2 oligomers are formed within the glyco-
calyx layer. Such aggregates may contribute to trigger
FGFR activity. Overall, these results show the effect of the
different grafting densities. The higher the concentration
of HS chains, the slower the FGF-2s flow and the closer
they get to the membrane. Also, the high HS concentration
allow the temporal formation of large aggregates.CONCLUSIONS
We use large-scale MD simulations to present the structure
and short time dynamics of the glycocalyx layer. We have
Flow Response of the Glycocalyx 241built the most detailed to-date model of the glycocalyx,
composed of HS sugar chains connected to transmembrane
Syn-4 dimers embedded in a POPC lipid bilayer.
We evaluated four HS sequences containing different
degrees of sulfonation, including a sequence with regions
for FGF and antithrombin binding. Our results revealed
that Syn-4 has a-helical segments in the ectodomain, but
it is unfolded in the segments where the HS chains are
linked. Furthermore, HS chains remain extended indepen-
dently of the sulfonation pattern.
We examined the glycocalyx conformation under shear
flow. Under moderate shear forces, we observed stretching
of HS chains, thinning of the glycocalyx thickness, and
bending of the Syn-4 cytoplasmic domain. This last result
shows that shear stress can exert influence on intracellular
structures through mechanotransduction.
We explored the binding of FGF proteins to the glycoca-
lyx layer. We used Grid-SMD methodology to simplify
the glycocalyx model, reducing the system’s size from
5,700,000 to 20,000 atoms. We observed an increase of
the FGF concentration near negative charges on the HS
chains, leading to FGF oligomerization.
Overall, our results provide insights in the structure of
glycocalyx layer and its dynamics, albeit for nanosecond
timescales. Our findings motivate the need for further
improvements; for example, adding different proteoglycans
and sugar chains, including more atomic complexity into
the glycocalyx grids, and suitable coarse-graining of
the glycocalyx network to reach longer timescales. We
envision that simulations of flow in capillaries that accu-
rately include the effects of the glycocalyx will lead to a
more comprehensive understanding of blood flow in health
and disease.SUPPORTING MATERIAL
Directions on obtaining glycocalix structures and Grid-SMD simulations,
two figures, one table, and three movies are available at http://www.
biophysj.org/biophysj/supplemental/S0006-3495(13)01201-0.
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